Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists

NEXT STORY
F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021
PREV STORY
Iovance Biotherapeutics to Present at Upcoming Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027, Growing at a CAGR of 7% From 2020 with COVID-19 Impact- Meticulous Research® Analysis

author_avatar
NASDAQ Market News

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017

PARSIPPANY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

author_avatar
NASDAQ Market News

Voltron Therapeutics, Inc. Executes Manufacturing Agreement with Global Pharmaceutical Contract Development and Manufacturing Organization

author_avatar
NASDAQ Market News